Article Details
Retrieved on: 2024-06-17 21:55:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In December 2023, the FDA approved the first gene therapies to treat patients with Sickle Cell Disease. In June 2024, Syngenta opened rights to genome ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here